Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

MetaVia Reports $4.6 Million Third Quarter Loss and DA-1726 Data

None

MetaVia (MTVA) reported a net loss of $4.6 million, or $0.69 per basic and diluted share, for the third quarter ended September 30, 2026. The clinical-stage biotechnology company had $8.8 million in cash and cash equivalents at quarter-end.

The company also reported interim Phase 1 Part 3B results for DA-1726, including a 68.1% placebo-adjusted reduction in liver fat and 13.5% placebo-adjusted weight loss at Day 109.

  • Third-quarter R&D expense was approximately $2.6 million, compared with approximately $1.9 million a year earlier.
  • Third-quarter G&A expense was approximately $2.1 million, compared with approximately $1.6 million a year earlier.
  • Total operating expenses were approximately $4.7 million, up from approximately $3.5 million in the prior-year quarter.
  • MetaVia expects full Phase 1 Parts 3A and 3B data for DA-1726 in the first quarter of 2027.
  • A 48-week Phase 2 study of DA-1726 in MetALD and ALD is targeted to begin in the second half of 2027.
  • The company appointed Sarah Browne, M.D., as chief medical officer in October 2026.

$MTVA Hedge Fund Activity

We have seen 8 institutional investors add shares of $MTVA stock to their portfolio, and 5 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

  • JANE STREET GROUP, LLC removed 31,442 shares (-25.4%) from their portfolio in Q3 2026, for an estimated $49,363
  • VIRTU FINANCIAL LLC added 29,933 shares (+inf%) to their portfolio in Q2 2026, for an estimated $42,804
  • UBS GROUP AG removed 12,947 shares (-100.0%) from their portfolio in Q3 2026, for an estimated $20,326
  • GEODE CAPITAL MANAGEMENT, LLC added 12,436 shares (+58.3%) to their portfolio in Q3 2026, for an estimated $19,524
  • SCIENTECH RESEARCH LLC added 12,014 shares (+inf%) to their portfolio in Q2 2026, for an estimated $17,180
  • FMR LLC added 750 shares (+inf%) to their portfolio in Q3 2026, for an estimated $1,177
  • BLACKROCK, INC. removed 472 shares (-98.5%) from their portfolio in Q2 2026, for an estimated $674

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles